Stocklytics score rationale: value 34, quality 43, growth 41.
Financials
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
356546000
414051000
453911000
481969000
422969000
495022000
553144000
604802000
671345000
780990000
U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The…
Forecast
Consensus Buy from 7 analysts. Average price target $90.00, +3.9% versus the current price. Low $90.00. High $90.00.
Analysts have an average 12-month price target of $90.00 for U.S. Physical Therapy (USPH), 3.8% above the current price of $86.68. Of 7 analysts covering the stock, 6 rate it Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
USPH price target
12-month price target
Low
$90.00
Average
$90.00
High
$90.00
The average is 3.8% above the current price of $86.68.
Is U.S. Physical Therapy a buy or sell?
Of 7 analysts, 6 rate U.S. Physical Therapy Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
U.S. Physical Therapy earnings and revenue forecast
The Stocklytics Score for USPH is 39 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
USPH forecast FAQs
What is the USPH price target?
$90.00 average, with a published range of $90.00 to $90.00.
Is U.S. Physical Therapy a buy or sell?
The consensus is Buy from 7 analysts. This is not a recommendation.
What is the U.S. Physical Therapy stock forecast for 2026?
Analysts' average EPS estimate for 2026 on file is $2.89. The average revenue estimate is $847.89 million.
What will USPH be worth in 2030?
No reliable forecast exists that far out.
When is U.S. Physical Therapy's next earnings report?
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.